Literature DB >> 17942402

Cell type-specific functions of the lysosomal protease cathepsin L in the heart.

Daniel Spira1, Jörg Stypmann, Desmond J Tobin, Ivonne Petermann, Christian Mayer, Sascha Hagemann, Olga Vasiljeva, Thomas Günther, Roland Schüle, Christoph Peters, Thomas Reinheckel.   

Abstract

Deficiency of the lysosomal cysteine protease cathepsin L (Ctsl) in mice results in a phenotype affecting multiple tissues, including thymus, epidermis, and hair follicles, and in the heart develops as a progressive dilated cardiomyopathy (DCM). To understand the role of Ctsl in the maintenance of regular heart morphology and function, it is critical to determine whether the DCM in Ctsl-/- mice is primarily because of the lack of Ctsl expression and activity in the cardiomyocytes or is caused by the additional extracardiac pathologies. Cardiomyocyte-specific expression of Ctsl in Ctsl-/- mice, using an alpha-myosin heavy chain promoter-Ctsl transgene, results in improved cardiac contraction, normal mRNA expression of atrionatriuretic peptide, normal heart weight, and regular ultrastructure of cardiomyocytes. Epithelial expression of cathepsin L2 (CTSL2) by a K14 promoter-CTSL2-transgene resulted in rescue of the Ctsl-/- hair loss phenotype. In these mice, cardiac atrionatriuretic peptide expression and end systolic heart dimensions were also significantly attenuated. However, cardiac contraction was not improved, and increased heart weight as well as the typical changes in lysosomal ultrastructure of Ctsl-/- hearts persisted. Myocardial fibrosis was detected in all Ctsl-/- mice irrespective of transgene-mediated cardiac Ctsl expression or extracardiac CTSL2 expression. Expression of collagen 1 was not enhanced in Ctsl-/- hearts, but a reduced collagenolytic activity suggests a role for Ctsl in collagen turnover by cardiac fibroblasts. We conclude that the DCM of Ctsl-/- mice is primarily caused by absence of the protease in cardiomyocytes, whereas the complex gross phenotype of Ctsl-deficient mice, i.e. the fur defect, results in additional stress to the heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942402     DOI: 10.1074/jbc.M703447200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

2.  From furless to heartless-unraveling the diverse functions of cathepsin L.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2009-01-25       Impact factor: 4.599

Review 3.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 4.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

5.  Formalin-Fixed, Paraffin-Embedded Tissues (FFPE) as a Robust Source for the Profiling of Native and Protease-Generated Protein Amino Termini.

Authors:  Zon Weng Lai; Juliane Weisser; Lars Nilse; Fabrizio Costa; Eva Keller; Martina Tholen; Jayachandran N Kizhakkedathu; Martin Biniossek; Peter Bronsert; Oliver Schilling
Journal:  Mol Cell Proteomics       Date:  2016-04-17       Impact factor: 5.911

6.  Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome.

Authors:  Stefan Tholen; Martin L Biniossek; Martina Gansz; Alejandro Gomez-Auli; Fee Bengsch; Agnes Noel; Jayachandran N Kizhakkedathu; Melanie Boerries; Hauke Busch; Thomas Reinheckel; Oliver Schilling
Journal:  Mol Cell Proteomics       Date:  2012-12-10       Impact factor: 5.911

7.  Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment.

Authors:  Uta Schurigt; Rene Eilenstein; Mieczyslaw Gajda; Carola Leipner; Lisa Sevenich; Thomas Reinheckel; Christoph Peters; Bernd Wiederanders; Rolf Bräuer
Journal:  Inflamm Res       Date:  2012-06-07       Impact factor: 4.575

8.  Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.

Authors:  Qizhu Tang; Jun Cai; Difei Shen; Zhouyan Bian; Ling Yan; You-Xin Wang; Jie Lan; Guo-Qing Zhuang; Wen-Zhan Ma; Wei Wang
Journal:  J Mol Med (Berl)       Date:  2008-12-19       Impact factor: 4.599

Review 9.  Pathogenesis and Management of COVID-19.

Authors:  Khalid O Alfarouk; Sari T S AlHoufie; Samrein B M Ahmed; Mona Shabana; Ahmed Ahmed; Saad S Alqahtani; Ali S Alqahtani; Ali M Alqahtani; AbdelRahman M Ramadan; Mohamed E Ahmed; Heyam S Ali; Adil Bashir; Jesus Devesa; Rosa A Cardone; Muntaser E Ibrahim; Laurent Schwartz; Stephan J Reshkin
Journal:  J Xenobiot       Date:  2021-05-21

10.  Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction.

Authors:  Yinan Hua; Yingmei Zhang; Julia Dolence; Guo-Ping Shi; Jun Ren; Sreejayan Nair
Journal:  Diabetes       Date:  2012-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.